Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything [Yahoo! Finance]
Agios Pharmaceuticals, Inc. (AGIO)
Last agios pharmaceuticals, inc. earnings: 4/30 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.agios.com/investor-overview
Company Research
Source: Yahoo! Finance
Pharmaceuticals (NASDAQ:AGIO) , reported the open-market sale of 2,959 shares of common stock for a total of roughly $82,000 on March 5, 2026, according to an SEC Form 4 filing Transaction summary Metric Value Shares sold (direct) Transaction value ~$82,260 Post-transaction shares (direct) Post-transaction value (direct ownership) ~$152,225 Transaction value based on SEC Form 4 weighted average sale price ($27.80); post-transaction value based on March 31, 2026 market close ($29.61). Key questions What was the nature of this transaction? This transaction was triggered by the vesting of 8,100 restricted stock units (RSUs). When RSUs vest, the shares are treated as taxable income, and it is standard practice for insiders to sell a portion of those shares immediately to cover the resulting tax bill. That is exactly what happened here: Krishnan received 8,100 shares from RSU vesting and sold 2,959 of them (about 37%) in an automatic, pre-planned transaction to sa
Show less
Read more
Impact Snapshot
Event Time:
AGIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AGIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AGIO alerts
High impacting Agios Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AGIO
News
- Agios Pharmaceuticals (AGIO) had its price target raised by The Goldman Sachs Group, Inc. from $28.00 to $32.00. They now have a "neutral" rating on the stock.MarketBeat
- Lost Money on Agios Pharmaceuticals, Inc.(AGIO)? You May Have Been Affected by Fraud- Contact Levi & KorsinskyPR Newswire
- Why Agios Pharmaceuticals Stock Is Up More Than 21% Today [Yahoo! Finance]Yahoo! Finance
- AGIO ALERT- The Gross Law Firm Has Commenced an Investigation on Behalf of Agios Pharmaceuticals, Inc. Shareholders Who Lost MoneyPR Newswire
- Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA [Yahoo! Finance]Yahoo! Finance
AGIO
Earnings
- 2/12/26 - Miss
AGIO
Sec Filings
- 4/2/26 - Form 144
- 4/2/26 - Form 144
- 4/2/26 - Form 144
- AGIO's page on the SEC website